First Set of Stricter German FDI Screening Rules Take Effect – More to Come Soon in Germany and Across the EU
First Set of Stricter German FDI Screening Rules Take Effect – More to Come Soon in Germany and Across the EU
Effective June 3, 2020, the screening of foreign direct investments (FDI) has been expanded in Germany, with a first tranche of new rules primarily affecting the healthcare sector. Drivers for the amendments are the EU Framework Regulation that took effect in April 2019 and will be fully applicable on October 11, 2020, and the COVID-19 pandemic situation, in line with the EU Commission’s guidance issued on March 25, 2020. However, certain newly introduced provisions apply to all business sectors, as will be the case with further amendments that are expected in the next few months. The expansion of FDI control schemes reflects a broader trend across a number of EU Member States and globally.
Here is what non-EU investors should have on their radar for transactions involving entities in Germany and other EU Member States:
On October 11, 2020, the EU framework for the screening of foreign direct investments will become fully applicable. EU Member State governments have begun to amend their FDI screening statutes to align with the EU Framework Regulation (EU Regulation No. 2019/452) adopted in March 2019 (see our previous alert). The German government has started legislative proceedings to amend statutory rules and regulations accordingly until October 2020.
The COVID-19 pandemic has accelerated the development of more strict and coordinated foreign investment screening on the national and European levels. In reaction to the outbreak of COVID-19, the European Commission issued guidelines to ensure a strong EU-wide approach to foreign investment screening (“EU Guidelines”). The German government split up the process to amend the Foreign Trade and Payments Regulation (Außenwirtschaftsverordnung or AWV) that was already under way, and adopted certain provisions to better protect healthcare related businesses by way of urgent amendment proceedings.
The EU Guidelines, published on March 25, 2020, urge the Member States to make full use of tools available to them to protect against the selling off of critical infrastructures and technologies. As 13 Member States currently do not have FDI screening mechanisms available, these governments are encouraged to set up full-fledged control regimes. The EU Commission notes that, particularly in situations of public health emergencies, an acquisition could result in a threat to the security or public order of a Member State.
The EU Commission clarifies that the EU Framework Regulation applies to all sectors of the economy and is not subject to any thresholds. It emphasizes that the need for screening may depend on the strategic importance of the target rather than the value of the transaction.
In the EU Commission’s view, even portfolio investments may threaten public order or security. Although a threat may be less likely in such a scenario because the investor generally does not gain control or other effective influence over the target, a minority investment could still be a concern if the investor obtains a so-called qualified shareholding under national company law.
The EU Commission also reminds that, in view of the principle of free movement of capital, restrictions of foreign investments need to be justified by legitimate general public interests. Purely economic objectives are generally insufficient, while public health, financial stability and other fundamental public interests may provide a basis to block or restrict certain acquisitions.
FDI screening in Germany is governed by the Foreign Trade Act (Außenwirtschaftsgesetz or AWG) and the respective underlying regulations (AWV). Revisions to both instruments are under way, in addition to the most recent amendments of the AWV that came into effect on June 3, 2020.
The urgently adopted amendment to the AWV is intended to maintain a functioning healthcare system in Germany by expanding the list of companies that are particularly relevant for public order or security, and to establish that where acquisitions by non-EU investors of 10% or more of a company’s voting rights are proposed, the German government must be notified. So far, the list only includes operators of critical infrastructures, companies developing software to use critical infrastructures, companies in the media industry and a limited number of other sensitive businesses.
The expanded list now also includes:
The new rules further clarify that asset deals are also included in the scope of the German FDI screening regime. This was already the case, but the government clarified its established practice.
As suggested by the EU Framework Regulation, under the revised German AWV provisions, another consideration, inter alia, is if the investor is directly or indirectly controlled by the government of a third country, which includes other state bodies or armed forces. The new rules further specify that control in this context can exist based on ownership, or by way of funding by the government or other state entities or armed forces, if such funding exceeds an insignificant (marginal) level, which however is not further specified.
The German government also introduced draft amendments to the AWG and is preparing further changes to the AWV. The proposed provisions currently subject to the parliamentary or ministerial legislative processes are supposed to align the German rules with the EU Framework Regulation and include the following:
(1) enable the acquirer to exercise voting rights directly or indirectly,
(2) grant the acquirer the right to receive a claim for payment of profits or an economic equivalent, or
(3) provide or otherwise disclose to the acquirer certain company information of the target, provided that such information relates to divisions or objects of the enterprise which are subject to the screening.
With the full applicability of the EU Framework Regulation as of October 11, 2020, non-EU investors face considerable changes in the screening of their investments in EU-based target companies.
These developments not only concern the timeline for screening procedures due to the cooperation mechanism implemented by the EU Framework Regulation, the scope of covered critical or sensitive business sectors will be considerably expanded as well. The German Ministry of Economics, the competent authority that conducts the screening process for targets based in Germany, will have additional leeway in its decision-making. Similarly, under the new provisions introduced in Spain at the end of March 2020 and in France effective April 1, 2020, other EU Member States have adopted laws and regulations to comply with the EU Framework Regulation, and further national governments will follow these paths.
Transactions involving a number of EU-based companies in different EU Member States will require a multijurisdictional analysis to identify notification requirements and related obligations in order to ensure compliance with FDI control rules in the same way that investors are already used to under merger control rules.